Evidence map›Paper›PMID 30241149›Full record

ArticleJournal of global oncology2018

Novel Pilot Curriculum for International Education of Lymphoma Management Using E-Contouring.

Raymond B Mailhot Vega, Omar F Ishaq, Inaya Ahmed, Luis Rene, Beatriz E Amendola, Kenneth S Hu

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Opportunities in Telemedicine, Lessons Learned After COVID-19 and the Way Into the Future.International journal of radiation oncology, biology, physics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Raymond B Mailhot VegaRaymond B. Mailhot Vega, Omar F. Ishaq, Inaya Ahmed, and Kenneth S. Hu, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY; Luis Rene, Centro de Radioterapia, Rosario, Argentina; and Beatriz E. Amendola, Innovative Cancer Institute, Miami, FL.
Omar F IshaqRaymond B. Mailhot Vega, Omar F. Ishaq, Inaya Ahmed, and Kenneth S. Hu, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY; Luis Rene, Centro de Radioterapia, Rosario, Argentina; and Beatriz E. Amendola, Innovative Cancer Institute, Miami, FL.
Inaya AhmedRaymond B. Mailhot Vega, Omar F. Ishaq, Inaya Ahmed, and Kenneth S. Hu, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY; Luis Rene, Centro de Radioterapia, Rosario, Argentina; and Beatriz E. Amendola, Innovative Cancer Institute, Miami, FL.
Luis ReneRaymond B. Mailhot Vega, Omar F. Ishaq, Inaya Ahmed, and Kenneth S. Hu, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY; Luis Rene, Centro de Radioterapia, Rosario, Argentina; and Beatriz E. Amendola, Innovative Cancer Institute, Miami, FL.
Beatriz E AmendolaRaymond B. Mailhot Vega, Omar F. Ishaq, Inaya Ahmed, and Kenneth S. Hu, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY; Luis Rene, Centro de Radioterapia, Rosario, Argentina; and Beatriz E. Amendola, Innovative Cancer Institute, Miami, FL.
Kenneth S HuRaymond B. Mailhot Vega, Omar F. Ishaq, Inaya Ahmed, and Kenneth S. Hu, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY; Luis Rene, Centro de Radioterapia, Rosario, Argentina; and Beatriz E. Amendola, Innovative Cancer Institute, Miami, FL.
Roswell Park Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe International Lymphoma Radiation Oncology Group (ILROG) published consensus guidelines on the management of Hodgkin disease (HD) and nodal non-Hodgkin lymphoma (NHL), which became the most downloaded articles from International Journal of Radiation Oncology, Biology, and Physics. E-contouring workshops allow for interactive didactic sessions, allowing participants to see case-based contouring in real time. A pilot 1-hour curriculum was developed with the objective of reviewing ILROG guidelines for HD and NHL management with incorporation of e-contouring tools. This represents the first international education intervention in Spanish using e-contouring with a pre- and postintervention questionnaire.

methodsA 1-hour presentation was prepared in Spanish reviewing the ILROG recommendations for HD and NHL. The review was followed by the author's demonstration of contour creation using patients with HD and NHL prepared for the American Society for Radiation Oncology's 2015 e-contouring lymphoma session. A five- question evaluation was prepared and administered before and after intervention. A two-tailed paired t test was performed to evaluate any significant change in test value before and after intervention.

resultsA total of nine quizzes were collected before and after the intervention. The average test score before the intervention was 75.6%, and the average test score after the intervention was 86.7% ( P = .051). Four students scored 100% on both the pre- and postintervention evaluations, and no student had a decrease in score from pre- to postintervention evaluation. The topic with the lowest score tested dose consideration.

conclusionA substantial but nonsignificant improvement in test evaluation was seen with this pilot curriculum. This pilot intervention identified obstacles for truly interactive didactic sessions that, when addressed, can lead to fully developed interactive didactic sessions.

Indexed as

ConsensusCurriculumHodgkin DiseaseHumansInternetLymphoma, Non-HodgkinPilot ProjectsPositron-Emission TomographyPractice Guidelines as TopicTelemedicine

Identifiers

PMID30241149
PMCPMC6223383
OpenAlexW2783901946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.